Intensity Therapeutics, Inc. (INTS)

Price & Market Data

Price: $4.71

Daily Change: $0.00 / 0.00%

Daily Range: $4.59 - $4.77

Market Cap: $12,730,282

Daily Volume: 15,232

Performance Metrics

1 Week: -1.25%

1 Month: -10.21%

3 Months: -22.89%

6 Months: -49.67%

1 Year: -49.25%

YTD: -53.10%

About Intensity Therapeutics, Inc. (INTS)

Quick market take on Intensity Therapeutics, Inc. (INTS). Current price: 4.71, daily change: $0.00 / 0.00%. Market cap: 12,730,282. Performance over 1-week and 1-month.

Company Details

Employees: 16

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer relapse and metastasis in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.

Selected stocks

Odysight.ai Inc. (ODYS)

Able View Global Inc. (ABLV)

Yunhong Green CTI Ltd. (YHGJ)

MFS Government Markets Income Trust (MGF)

Solowin Holdings (AXG)